2-Methoxyestradiol clinical trials
- studies test it
- 5
- open now
- 0
- in phase 3
- 0
- first study started
- 2001
How each study uses 2-Methoxyestradiol is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
Studies by the year they started
5 studies that test it; most in 2001 (2)
| Year | Studies |
|---|---|
| 2001 | 2 |
| 2002 | 1 |
| 2006 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 3 · Other 2
CASI Pharmaceuticals, Inc. (3) · National Cancer Institute (NCI) (2)
Studies
Open first, then newest update. How each study uses 2-Methoxyestradiol is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 5
- 2-Methoxyestradiol in Treating Patients With Advanced Solid TumorsCompletedPhase 1National Cancer Institute (NCI)NCT00030095Written as 2-methoxyestradiol
- 2-Methoxyestradiol in Treating Patients With Advanced Solid TumorsCompletedPhase 1National Cancer Institute (NCI)NCT00028821Written as 2-methoxyestradiol
- A Combination Study to Determine the Safety and Efficacy of Panzem NCD With Avastin in Metastatic Carcinoid TumorsCompletedPhase 2CASI Pharmaceuticals, Inc.NCT00328497Written as Panzem (2-methoxyestradiol) NCD, Avastin (Bevacizumab)
- A Phase 2 Study With Panzem in Patients With Relapsed or Plateau Phase Multiple MyelomaCompletedPhase 2CASI Pharmaceuticals, Inc.NCT00592579Written as 2-methoxyestradiol
- Safety and Efficacy Study of Panzem NCD to Treat GlioblastomaCompletedPhase 2CASI Pharmaceuticals, Inc.NCT00306618Written as Panzem Nanocrystal Colloidal Dispersion
Codes
What other systems call 2-Methoxyestradiol · ClinicalTrials.gg INT006761
- MeSH (NLM) D0000775842-MethoxyestradiolConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 6I2QW73SR52-METHOXYESTRADIOLConfirmed FDA, NLM, Wikidata
- Wikidata Q45968972-methoxyestradiolConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C9652-MethoxyestradiolOne source FDA
- DrugBank DB02342One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D000077584 | 2-Methoxyestradiol | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 6I2QW73SR5 | 2-METHOXYESTRADIOL | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q4596897 | 2-methoxyestradiol | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C965 | 2-Methoxyestradiol | One source FDA |
| DrugBank | DB02342 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.